PT96828A - Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue - Google Patents

Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue

Info

Publication number
PT96828A
PT96828A PT96828A PT9682891A PT96828A PT 96828 A PT96828 A PT 96828A PT 96828 A PT96828 A PT 96828A PT 9682891 A PT9682891 A PT 9682891A PT 96828 A PT96828 A PT 96828A
Authority
PT
Portugal
Prior art keywords
agent
diabetic
blood coagulation
gangrena
coagulation factor
Prior art date
Application number
PT96828A
Other languages
English (en)
Other versions
PT96828B (pt
Inventor
Hiroshi Nin
Masahiko Shikano
Satoshi Tanaka
Masao Ikdea
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of PT96828A publication Critical patent/PT96828A/pt
Publication of PT96828B publication Critical patent/PT96828B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT96828A 1990-02-20 1991-02-20 Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue PT96828B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2037284A JPH03240738A (ja) 1990-02-20 1990-02-20 糖尿病性壊疽治療剤
EP91102606A EP0499679B1 (en) 1990-02-20 1991-02-22 Therapeutic agent for diabetic gangrene

Publications (2)

Publication Number Publication Date
PT96828A true PT96828A (pt) 1991-11-29
PT96828B PT96828B (pt) 1998-07-31

Family

ID=40202967

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96828A PT96828B (pt) 1990-02-20 1991-02-20 Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue

Country Status (13)

Country Link
US (1) US5164373A (pt)
EP (1) EP0499679B1 (pt)
JP (1) JPH03240738A (pt)
KR (1) KR0184008B1 (pt)
AT (1) ATE128358T1 (pt)
AU (1) AU647078B2 (pt)
CA (1) CA2036592C (pt)
DE (1) DE69113437T2 (pt)
DK (1) DK0499679T3 (pt)
ES (1) ES2077698T3 (pt)
GR (1) GR3017672T3 (pt)
IE (1) IE69393B1 (pt)
PT (1) PT96828B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3337488B2 (ja) * 1992-03-06 2002-10-21 アベンティス ファーマ株式会社 切迫流産治療剤
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
CA2722230C (en) * 2008-04-21 2016-08-23 Novo Nordisk Health Care Ag Dry transglutaminase composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3419581A1 (de) * 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
JPS63196520A (ja) * 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
US4904751A (en) * 1987-12-21 1990-02-27 Texaco Chemical Company N,N'-dialkyl substituted polyoxyalklene amines as curing agents for blocked isocyanates
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
IE69393B1 (en) 1996-09-18
IE910565A1 (en) 1991-08-28
PT96828B (pt) 1998-07-31
CA2036592A1 (en) 1991-08-21
AU7117891A (en) 1991-08-22
EP0499679A1 (en) 1992-08-26
DK0499679T3 (da) 1996-02-05
JPH0561253B2 (pt) 1993-09-06
DE69113437T2 (de) 1996-04-11
GR3017672T3 (en) 1996-01-31
KR0184008B1 (ko) 1999-05-01
KR910021244A (ko) 1991-12-20
EP0499679B1 (en) 1995-09-27
ATE128358T1 (de) 1995-10-15
DE69113437D1 (de) 1995-11-02
JPH03240738A (ja) 1991-10-28
ES2077698T3 (es) 1995-12-01
CA2036592C (en) 2004-04-06
AU647078B2 (en) 1994-03-17
US5164373A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
ES2115589T3 (es) Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
SE8504720L (sv) Ny lekemedelsberedning
ATE111341T1 (de) Haarkosmetisches präparat.
NO2002009I2 (no) Tiotropium
GR1000918B (el) Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.
PT83873B (pt) Processo de preparacao de medicamentos contendo hexadecilfosfocolina
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
DK261490D0 (da) New pharmaceutical compound
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
PT96828A (pt) Processo para a preparacao de um agente para a terapia de gangrena diabetica,contendo o factor xiii de coagulacao do sangue
SE8605503D0 (sv) Novel medicinal use
ES2018796B3 (es) Procedimiento para obtener un agente conservador de la madera
NO922136D0 (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
PT82202B (pt) Processo para a preparacao de compostos de poliprenilo
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
NO873934D0 (no) Fremgangsmaate for forbedret saarheling.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
ATE30582T1 (de) Ungesaettigte arylalkylammoniumsalze.
SE8704093D0 (sv) Terapeutiska medel och anvendning derav
ES485116A1 (es) Procedimiento para la obtencion de plasma sanguineo estable y esteril
DE3778925D1 (de) Hydroxamsaeure von 7-oxabicycloheptan substituierten aethern.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910725

FG3A Patent granted, date of granting

Effective date: 19980413

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20121015

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130415